Neuralgia and neuritis, unspecified

M13_NEURALGIA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M79.2 Hospital discharge: ICD-9 — 7292 Hospital discharge: ICD-8 — 71491 Cause of death: ICD-10 — M79.2 Cause of death: ICD-9 — 7292 Cause of death: ICD-8 — 71491 2 out of 7 registries used, show all original rules.	2033
4. Check minimum number of events None	2033
5. Include endpoints None	2033
6. Filter based on genotype QC (FinnGen only)	2033

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M79
Name in latin: Neuralgia non specificata

NAME	M13_NEURALGIA
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M792
HD_ICD_9	7292
HD_ICD_8	71491
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M792
COD_ICD_9	7292
COD_ICD_8	71491
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Neuralgia and neuritis, unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13267	7813	5376
Only index persons	12535	7499	5036
Unadjusted period prevalence (%)
Whole population	0.19	0.22	0.15
Only index persons	0.24	0.28	0.19
Median age at first event (years)
Whole population	54.43	54.47	54.50
Only index persons	53.76	53.74	53.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2033	1305	728
Unadjusted period prevalence (%)	0.40	0.44	0.32
Median age at first event (years)	53.67	52.16	56.38

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1811: Matched controls
18111

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N03AX12

ATC

gabapentin; oral

14.5

323.0

845

1030

N03AX16

ATC

pregabalin; oral

11.6

323.0

1046

1908

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

10672.6

323.0

1741

M79.6

ICD-10 Finland

Pain in limb

6.1

253.9

935

2711

N02AX02

ATC

tramadol; systemic, rectal

5.5

246.0

1131

4208

N06AX21

ATC

duloxetine; oral

9.5

230.0

523

740

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

8.6

199.2

480

730

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.7

139.3

888

3756

N06AA09

ATC

amitriptyline; systemic

6.9

134.9

371

653

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.9

129.1

495

1296

N02AA05

ATC

oxycodone; systemic

4.9

116.1

433

1087

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

39.8

116.0

147

R51.80

ICD-10 Finland

Headache

4.8

115.8

447

1163

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.1

112.9

997

5104

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.8

112.8

428

1090

R52.2

ICD-10 Finland

Other chronic pain

15.2

112.5

192

140

N02AJ06

ATC

codeine and paracetamol; systemic

3.2

111.1

838

3827

M54.4

ICD-10 Finland

Lumbago with sciatica

4.5

110.8

460

1282

R07.4

ICD-10 Finland

Chest pain, unspecified

3.5

107.3

638

2424

M54.5

ICD-10 Finland

Low back pain

3.2

107.1

761

3307

M01AH05

ATC

etoricoxib; oral

3.0

102.0

1209

7314

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

17.0

101.9

166

107

M79.0

ICD-10 Finland

Rheumatism, unspecified

46.1

101.7

125

A02BC02

ATC

pantoprazole; systemic

3.0

100.1

1301

8306

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

6.8

99.6

271

458

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

23.4

98.3

143

M25.5

ICD-10 Finland

Pain in joint

3.3

97.3

646

2627

N02BE01

ATC

paracetamol; systemic, rectal

4.2

91.9

1648

12776

M79.1

ICD-10 Finland

Myalgia

4.9

91.7

331

784

Z01.8

ICD-10 Finland

Other specified special examinations

3.4

90.9

538

1988

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.1

90.1

652

2788

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

5.5

88.2

286

599

M03BX02

ATC

tizanidine; oral

2.8

88.1

1260

8175

N06AX11

ATC

mirtazapine; oral

2.9

87.3

735

3458

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.2

83.0

533

2072

A02BC05

ATC

esomeprazole; systemic

2.7

82.3

864

4600

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

82.0

560

2270

R52.9

ICD-10 Finland

Pain, unspecified

5.5

79.8

255

522

A02BC03

ATC

lansoprazole; oral

2.9

79.2

648

2947

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.3

78.3

261

560

7292A

ICD-9 Finland

Other disorders of soft tissues, Neuralgia, neuritis and radiculitis, unspecified

+∞

77.6

N06AX16

ATC

venlafaxine; oral

3.6

77.4

400

1308

M79.7

ICD-10 Finland

Fibromyalgia

17.8

76.7

122

M48.0

ICD-10 Finland

Spinal stenosis

4.6

74.2

282

695

H02AB06

ATC

prednisolone; systemic

2.5

72.9

928

5375

N03AF01

ATC

carbamazepine; oral, rectal

6.6

72.3

198

332

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

7.4

71.8

180

266

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.4

71.2

402

1400

M01AB05

ATC

diclofenac; systemic, rectal

2.5

70.5

1279

8859

M01AE03

ATC

ketoprofen; systemic, rectal

2.5

69.7

769

4094

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.7

69.0

599

2776

G44.2

ICD-10 Finland

Tension-type headache

3.7

68.7

341

1069

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

7.2

66.1

168

253

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.8

65.4

314

954

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.0

63.5

280

788

M19.0

ICD-10 Finland

Primary arthrosis of other joints

4.9

63.0

221

497

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

4.3

61.8

249

644

S18

ICPC

Laceration/cut

2.4

61.7

807

4606

UJF32

NOMESCO Finland

Coloscopy

2.7

61.5

545

2523

R06.0

ICD-10 Finland

Dyspnoea

2.7

60.5

498

2206

A06AC01

ATC

ispaghula (psylla seeds); oral

2.7

59.9

518

2359

N03AX09

ATC

lamotrigine; oral

5.9

59.2

175

322

L03

ICPC

Low back symptom/complaint

2.7

58.9

508

2307

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

5.8

58.5

176

331

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.3

58.4

235

605

J01DB01

ATC

cefalexin; oral

2.7

58.4

1521

12008

L08

ICPC

Shoulder symptom/complaint

3.0

58.3

384

1471

N03AE01

ATC

clonazepam; systemic

5.3

57.8

188

387

M89.0

ICD-10 Finland

Algoneurodystrophy

33.9

57.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

57.4

811

4755

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

57.2

249

690

M01AE02

ATC

naproxen; oral, rectal

2.2

56.8

1067

7116

G50.1

ICD-10 Finland

Atypical facial pain

13.9

56.6

N05CF01

ATC

zopiclone; oral

2.4

56.3

651

3449

M54.1

ICD-10 Finland

Radiculopathy

7.9

56.2

133

179

P01AB01

ATC

metronidazole; oral, rectal

2.2

55.8

810

4788

M54.6

ICD-10 Finland

Pain in thoracic spine

4.9

55.1

191

422

R03AC02

ATC

salbutamol; inhalant

2.2

54.8

997

6509

A01

ICPC

Pain general/multiple sites

4.6

54.7

205

491

L17

ICPC

Foot/toe symptom/complaint

2.6

54.6

493

2284

AA1AD

NOMESCO Finland

CT of head and brain

2.6

53.5

475

2174

R07.3

ICD-10 Finland

Other chest pain

3.9

53.0

236

665

R52.1

ICD-10 Finland

Chronic intractable pain

35.3

52.6

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.6

52.2

258

794

G56.4

ICD-10 Finland

Causalgia

98.0

52.1

J01AA02

ATC

doxycycline; systemic

2.4

51.9

1441

11255

X59

ICD-10 Finland

Exposure to unspecified factor

2.8

50.7

381

1573

N06AA10

ATC

nortriptyline; systemic

9.8

50.1

104

112

A06AD11

ATC

lactulose; oral

3.1

50.1

308

1115

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

49.4

304

1100

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

81.1

49.2

WX110

NOMESCO Finland

Local anesthesy

2.1

48.6

1271

9475

A02BC01

ATC

omeprazole; systemic

2.4

48.5

536

2733

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

48.2

347

1392

M01AC06

ATC

meloxicam; systemic, rectal

2.2

48.1

682

3912

N05BA04

ATC

oxazepam; oral

2.4

48.1

520

2620

M70.6

ICD-10 Finland

Trochanteric bursitis

3.5

48.1

245

770

SAA01

NOMESCO Finland

Simple examination of mouth

2.1

47.7

1296

9773

G54.0

ICD-10 Finland

Brachial plexus disorders

10.3

47.6

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.8

47.1

361

1501

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.1

46.9

909

5940

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

46.9

549

2871

UKC02

NOMESCO Finland

Cystoscopy

2.9

46.3

322

1259

N05AH04

ATC

quetiapine; oral

2.7

46.1

367

1559

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

46.1

767

4690

R42

ICD-10 Finland

Dizziness and giddiness

2.5

45.9

431

2009

M77.1

ICD-10 Finland

Lateral epicondylitis

4.6

45.8

169

397

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

27.1

45.7

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.0

45.5

1023

7063

M54.2

ICD-10 Finland

Cervicalgia

4.2

45.1

183

471

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.4

44.6

241

790

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

44.4

555

2978

J01FF01

ATC

clindamycin; systemic

2.3

44.3

528

2772

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

44.2

354

1506

L01

ICPC

Neck symptom/complaint

2.9

44.2

301

1159

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.4

43.0

438

2121

L28

ICPC

Limited function/disability (L)

2.8

43.0

304

1197

J01MA02

ATC

ciprofloxacin; systemic

2.1

42.9

717

4356

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.0

42.3

181

489

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

42.0

419

2006

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

41.0

524

2822

M03BX01

ATC

baclofen; systemic

11.3

40.8

G50.0

ICD-10 Finland

Trigeminal neuralgia

10.7

40.7

SPAT1263

SPAT

Sampling

2.0

40.3

786

5041

M54.3

ICD-10 Finland

Sciatica

4.5

39.8

148

349

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

39.6

333

1449

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.1

39.3

553

3096

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.4

38.9

204

651

M01AX17

ATC

nimesulide; oral

2.3

38.7

444

2266

M01AH01

ATC

celecoxib; oral (coxibs)

2.5

38.4

338

1504

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

38.2

577

3323

N05BA01

ATC

diazepam; systemic, rectal

2.7

37.9

288

1178

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.2

37.8

220

758

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.9

37.4

968

6823

WX704

NOMESCO Finland

Intubation

3.5

37.2

187

577

R53

ICD-10 Finland

Malaise and fatigue

2.3

37.1

391

1908

M01AE01

ATC

ibuprofen; systemic, rectal

2.5

37.1

1624

14046

C07AB07

ATC

bisoprolol; oral

1.9

36.9

792

5208

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

6.2

36.9

103

175

X58

ICD-10 Finland

Exposure to other specified factors

2.7

36.5

272

1100

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.4

36.4

362

1713

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

5.6

36.2

110

208

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.9

36.2

781

5136

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

36.1

339

1558

J02AC01

ATC

fluconazole; systemic

1.9

35.9

769

5037

J01DA01

ATC

[U] cefalexin; systemic

1.9

35.8

1132

8504

M02AA07

ATC

piroxicam; topical

2.0

35.8

632

3851

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

6.5

35.6

152

L12

ICPC

Hand/finger symptom/complaint

2.6

35.5

281

1175

G43.9

ICD-10 Finland

Migraine, unspecified

4.1

35.5

145

374

D01

ICPC

Abdominal pain/cramps general

2.9

35.2

232

867

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

5.4

35.2

110

215

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

35.2

278

1159

B01AB05

ATC

enoxaparin; parenteral

2.0

35.2

551

3200

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.0

35.2

620

3770

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.0

34.9

221

802

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.6

34.9

170

511

SPAT1153

SPAT

Removal of sutures

2.0

34.8

575

3403

M01AH02

ATC

rofecoxib; oral

2.8

34.8

251

991

L86

ICPC

Back syndrome with radiating pain

4.4

34.8

133

322

XA402

NOMESCO Finland

ENMG

7.8

34.8

110

R20.2

ICD-10 Finland

Paraesthesia of skin

3.7

34.7

162

470

ZXA00

NOMESCO Finland

Right side

2.1

34.6

464

2524

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

34.3

311

1399

R4110

NOMESCO Finland

Physiotherapy

2.1

34.1

482

2676

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

34.1

384

1926

R51.81

ICD-10 Finland

Facial pain NOS

7.1

33.6

123

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

33.6

695

4465

G56.2

ICD-10 Finland

Lesion of ulnar nerve

6.8

33.5

131

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.9

33.4

170

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

33.3

165

502

N01

ICPC

Headache

3.0

33.2

213

782

M47.9

ICD-10 Finland

Spondylosis, unspecified

6.6

33.1

137

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

4.9

32.7

111

238

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.5

32.3

281

1236

A02BA02

ATC

ranitidine; systemic

2.2

32.1

361

1804

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.9

32.0

137

369

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.1

31.9

187

645

M77.4

ICD-10 Finland

Metatarsalgia

4.6

31.8

116

268

N05CF02

ATC

zolpidem; oral

2.3

31.6

353

1758

L02

ICPC

Back symptom/complaint

3.1

31.5

188

655

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

6.9

31.5

120

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.1

31.2

127

327

WX290

NOMESCO Finland

Other blockade of nerve

1.8

30.9

786

5377

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.1

30.9

184

639

N04BC05

ATC

pramipexole; oral

3.4

30.5

157

492

N02AC04

ATC

dextropropoxyphene; oral

5.7

30.4

165

K02.1

ICD-10 Finland

Caries of dentine

1.8

30.4

1003

7446

R50.9

ICD-10 Finland

Fever, unspecified

2.5

30.2

272

1215

L13

ICPC

Hip symptom/complaint

2.4

30.2

286

1311

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

4.5

30.2

111

259

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.3

29.9

115

280

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

29.9

213

832

R11

ICD-10 Finland

Nausea and vomiting

3.1

29.8

173

589

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.4

29.8

151

467

J01FA10

ATC

azithromycin; systemic

1.8

29.6

1032

7768

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.9

29.5

210

XF402

NOMESCO Finland

ECG with work load test

2.7

29.4

217

866

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

29.4

242

1029

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

6.1

29.4

140

NBG10

NOMESCO Finland

Acromioplastia

20.9

29.2

K30

ICD-10 Finland

Functional dyspepsia

2.8

29.2

208

811

UJD02

NOMESCO Finland

Gastroscopy

4.1

29.2

117

297

N06AB04

ATC

citalopram; systemic

2.1

29.1

406

2218

C07AA05

ATC

propranolol; systemic

2.1

29.1

380

2019

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

29.0

228

945

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.6

28.9

135

392

Z01.2

ICD-10 Finland

Dental examination

1.8

28.8

724

4898

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

28.8

132

377

L15

ICPC

Knee symptom/complaint

2.1

28.8

359

1873

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

7.3

28.7

N05CD07

ATC

temazepam; oral

2.6

28.7

237

1007

K07.60

ICD-10 Finland

Snapping jaw

4.1

28.7

115

292

N03AF02

ATC

oxcarbazepine; oral

5.0

28.6

199

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

12.8

28.6

SPAT1254

SPAT

Administration of medicine

2.4

28.5

271

1244

J01CA04

ATC

amoxicillin; systemic

1.9

28.5

1424

11957

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

28.4

895

6494

ZXA05

NOMESCO Finland

Left side

2.0

27.9

419

2355

R03DC03

ATC

montelukast; oral

2.3

27.8

296

1431

R10.2

ICD-10 Finland

Pelvic and perineal pain

7.1

27.7

101

SPAT1240

SPAT

Therapeutic discussion

2.6

27.6

222

931

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.7

27.5

1009

7636

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

4.5

27.5

100

231

ACC51

NOMESCO Finland

Release of median nerve

3.3

27.2

144

461

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.7

27.1

125

359

J01FA06

ATC

roxithromycin; oral

1.8

27.0

710

4842

Z71.8

ICD-10 Finland

Other specified counselling

2.0

27.0

422

2403

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.4

27.0

256

1170

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

26.8

404

2269

R13

ICD-10 Finland

Dysphagia

3.4

26.7

135

417

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.0

26.6

162

571

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

10.5

26.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

26.4

160

561

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

26.3

295

1460

N07BC02

ATC

methadone; systemic

52.5

26.2

M50.3

ICD-10 Finland

Other cervical disc degeneration

6.9

26.2

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

21.5

26.1

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.3

26.1

265

1253

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.2

26.1

142

464

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.0

26.0

159

562

WX725

NOMESCO Finland

Noninvasive ventilation

3.7

26.0

117

329

L16

ICPC

Ankle symptom/complaint

2.7

26.0

188

741

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

25.9

301

1513

K08.80

ICD-10 Finland

Toothache NOS

2.9

25.7

166

609

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.5

25.5

215

921

R01AD09

ATC

mometasone; nasal

1.7

25.5

779

5535

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.6

25.5

202

S06.0

ICD-10 Finland

Concussion

2.7

25.4

191

769

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

25.4

1106

8703

WX002

NOMESCO Finland

Sedation and analgesia

2.1

25.4

341

1826

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.4

25.3

130

406

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

12.1

25.3

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.4

25.1

128

398

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.2

25.1

138

454

TAB00

NOMESCO Finland

Lumbar puncture

3.8

25.0

109

298

C03CA01

ATC

furosemide; systemic

1.9

24.9

423

2479

M54.8

ICD-10 Finland

Other dorsalgia

4.2

24.9

240

WX200

NOMESCO Finland

Interscalenous plexus blockade

9.9

24.8

M65.3

ICD-10 Finland

Trigger finger

7.1

24.8

XKD00

NOMESCO Finland

Uroflowmetry

2.3

24.7

249

1171

D06

ICPC

Abdominal pain localized other

2.9

24.7

164

611

M67.4

ICD-10 Finland

Ganglion

4.4

24.7

218

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.6

24.6

195

807

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

24.6

193

796

R09

ICPC

Sinus symptom/complaint

2.9

24.6

159

582

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

9.7

24.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

24.5

169

646

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.2

24.4

153

F43.1

ICD-10 Finland

Post-traumatic stress disorder

6.5

24.4

101

SPAT1229

SPAT

Assessment of need for aid

3.0

24.4

151

539

M01AB55

ATC

diclofenac, combinations; oral

3.2

24.4

134

441

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.9

24.3

472

2893

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.7

24.1

126

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

10.5

24.1

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

24.0

110

314

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

23.1

23.9

Z00.0

ICD-10 Finland

General medical examination

2.0

23.9

326

1751

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.1

23.8

112

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.5

23.8

196

830

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

23.7

335

1825

R21

ICPC

Throat symptom/complaint

2.0

23.5

349

1939

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

11.2

23.4

M01AX05

ATC

glucosamine; oral

2.1

23.4

315

1679

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

23.4

332

1812

R01AD12

ATC

fluticasone furoate; nasal

1.8

23.2

524

3369

W19

ICD-10 Finland

Unspecified fall

2.7

23.2

173

691

K59.09

ICD-10 Finland

Constipation, unspecified

3.4

23.1

116

357

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

36.8

23.0

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

23.0

432

2611

J05AB01

ATC

aciclovir; systemic

1.9

23.0

378

2180

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

13.2

22.9

R05

ICPC

Cough

1.9

22.9

381

2206

N06AB10

ATC

escitalopram; oral

2.0

22.9

360

2040

M01AX01

ATC

nabumetone; oral

4.0

22.8

250

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

22.8

176

719

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

22.7

371

2135

M01AH03

ATC

valdecoxib; oral

3.2

22.6

124

407

L05

ICPC

Flank/axilla symptom/complaint

3.4

22.5

115

359

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.2

22.4

215

H92.0

ICD-10 Finland

Otalgia

3.5

22.3

109

328

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.3

22.1

203

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

22.1

249

1229

L09

ICPC

Arm symptom/complaint

3.8

21.9

254

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

9.0

21.9

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

25.4

21.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.7

21.7

154

597

H57.1

ICD-10 Finland

Ocular pain

4.5

21.6

180

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

21.5

700

4986

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

21.5

134

480

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.4

21.3

202

917

P03

ICPC

Feeling depressed

2.5

21.3

175

738

M77.0

ICD-10 Finland

Medial epicondylitis

8.1

21.3

Z50.1

ICD-10 Finland

Other physical therapy

3.4

21.2

107

330

N06AB06

ATC

sertraline; oral

2.3

21.2

204

935

A01AB09

ATC

miconazole; local oral

2.5

21.2

169

703

A03FA02

ATC

cisapride; oral, rectal

2.8

21.1

143

538

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

21.1

532

3521

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.8

21.1

145

553

G47.3

ICD-10 Finland

Sleep apnoea

1.9

21.0

339

1932

M75.8

ICD-10 Finland

Other shoulder lesions

5.2

21.0

131

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.2

21.0

116

383

KMAK

NOMESCO Finland

1.6

21.0

901

6895

SGA01

NOMESCO Finland

Tooth opening as first aid

2.0

21.0

281

1493

M13.9

ICD-10 Finland

Arthritis, unspecified

2.9

21.0

130

463

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.6

20.9

157

629

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

14.2

20.8

H02AB04

ATC

methylprednisolone; systemic

2.1

20.8

251

1274

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.5

20.8

100

298

R00.2

ICD-10 Finland

Palpitations

2.8

20.7

139

522

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.0

20.7

126

445

-1

NOMESCO Finland

1.7

20.7

570

3866

H01

ICPC

Ear pain/earache

2.4

20.6

193

873

R52.0

ICD-10 Finland

Acute pain

4.5

20.6

170

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.1

20.6

119

406

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

20.6

202

933

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

20.5

449

2843

WX702

NOMESCO Finland

Supraglottic ventilation device

3.3

20.4

107

340

R03BA05

ATC

fluticasone; inhalant

2.0

20.4

311

1734

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

20.4

200

A28

ICPC

Limited function/disability NOS

2.2

20.4

231

1142

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

14.4

20.4

D11

ICPC

Diarrhoea

2.3

20.3

203

945

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.9

20.3

128

462

R05

ICD-10 Finland

Cough

1.9

20.3

325

1848

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

20.3

178

779

L29

ICPC

Musculoskeletal sympt/complt other

2.9

20.3

130

473

G57.6

ICD-10 Finland

Lesion of plantar nerve

6.3

20.2

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

20.2

329

1883

R02

ICPC

Shortness of breath/dyspnoea

2.3

20.2

197

908

JAH01

NOMESCO Finland

Laparoscopy

3.3

20.2

104

327

R06AE07

ATC

cetirizine; oral

1.6

20.1

741

5429

H02AB07

ATC

prednisone; oral

2.1

20.0

252

1303

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

5.8

20.0

101

WX720

NOMESCO Finland

Own respiration

3.7

20.0

249

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

23.7

20.0

L14

ICPC

Leg/thigh symptom/complaint

2.8

19.9

133

497

R55

ICD-10 Finland

Syncope and collapse

2.3

19.8

185

836

SPAT1216

SPAT

Assessment of functional ability

2.1

19.7

242

1238

UJF30

NOMESCO Finland

Ileoscopy through colon

2.4

19.7

182

816

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

19.7

325

1867

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

4.3

19.6

174

A02BC04

ATC

rabeprazole; oral

2.6

19.6

153

629

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.3

19.5

198

931

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

6.0

19.4

N06AX22

ATC

agomelatine; oral

5.1

19.3

122

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

19.3

233

1183

R4120

NOMESCO Finland

Occupational therapy

3.0

19.3

116

405

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

2.5

19.3

163

698

K29.7

ICD-10 Finland

Gastritis, unspecified

4.1

19.3

191

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.9

19.2

211

R35

ICD-10 Finland

Polyuria

3.0

19.2

115

400

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.8

19.2

136

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.1

19.2

123

A11

ICPC

Chest pain NOS

2.7

19.2

134

516

N06AX03

ATC

mianserin; oral

3.3

19.2

306

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

19.1

119

424

TAC00

NOMESCO Finland

Peripheral nerve block

26.3

19.1

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.2

19.1

211

1027

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.3

19.0

180

817

R60.0

ICD-10 Finland

Localized oedema

2.4

19.0

177

796

WZA90

NOMESCO Finland

Other doctors statement

1.8

19.0

377

2305

H53.1

ICD-10 Finland

Subjective visual disturbances

2.9

19.0

123

451

EBA00

NOMESCO Finland

Extraction of tooth

1.7

19.0

534

3624

SPAT1211

SPAT

Application of soft bandage

2.5

18.9

161

693

F51.0

ICD-10 Finland

Nonorganic insomnia

2.1

18.9

238

1230

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

18.9

263

1416

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.9

18.9

130

A07AA02

ATC

nystatin; oral

2.9

18.8

117

417

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

18.8

735

5442

TAC99

NOMESCO Finland

Other blockade for chronic pain

17.3

18.7

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

18.6

215

1070

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

18.6

217

1084

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.4

18.6

280

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.7

18.6

136

535

NF1AA

NOMESCO Finland

Hip X-ray examination

2.6

18.6

140

562

R5599

NOMESCO Finland

Other rehabilitation service

5.1

18.6

119

R4110

SPAT

4.3

18.6

164

XG410

NOMESCO Finland

Flow-volume spirometry

3.6

18.6

249

NG4AA

NOMESCO Finland

Lower leg X-ray examination

4.2

18.5

174

D07AC01

ATC

betamethasone; topical

1.6

18.5

562

3891

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

6.2

18.5

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

18.5

657

4743

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

18.5

266

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

18.4

676

4915

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.7

18.2

457

2997

G81.9

ICD-10 Finland

Hemiplegia, unspecified

11.2

18.2

P06

ICPC

Sleep disturbance

2.3

18.2

179

827

D07AB02

ATC

hydrocortisone butyrate; topical

1.7

18.1

470

3108

R01AD08

ATC

fluticasone; nasal

1.7

18.1

480

3197

K59.0

ICD-10 Finland

Constipation

3.0

18.1

105

360

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.2

18.0

186

880

C10AA05

ATC

atorvastatin; oral

1.6

18.0

576

4040

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

18.0

146

613

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

17.9

145

605

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.4

17.9

152

654

S80.0

ICD-10 Finland

Contusion of knee

2.8

17.8

116

425

J01EA01

ATC

trimethoprim; systemic

1.7

17.8

428

2768

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

6.9

17.8

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

20.3

17.7

SPAT1260

SPAT

Consultation of another employee

1.9

17.7

306

1778

A03

ICPC

Fever

1.9

17.7

267

1478

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

17.7

417

2678

G04CA02

ATC

tamsulosin; oral

1.9

17.6

281

1588

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.4

17.5

150

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.4

17.5

261

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

17.5

528

3637

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

7.0

17.5

D19

ICPC

Teeth/gum symptom/complaint

1.7

17.5

428

2782

C05AA08

ATC

fluocortolone; rectal, topical

2.0

17.4

240

1282

SPAT1301

SPAT

No procedures

1.6

17.3

508

3472

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.6

17.3

135

552

S22.3

ICD-10 Finland

Fracture of rib

2.9

17.3

107

383

P01

ICPC

Feeling anxious/nervous/tense

2.2

17.3

178

841

S29

ICPC

Skin symptom/complaint other

1.9

17.1

272

1536

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.3

17.1

154

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

17.1

287

1652

L29.9

ICD-10 Finland

Pruritus, unspecified

4.9

17.0

118

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

7.4

17.0

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

17.0

154

685

XF404

NOMESCO Finland

Ambulatory ECG

2.3

16.9

164

753

R25.2

ICD-10 Finland

Cramp and spasm

5.2

16.9

102

C10AC01

ATC

colestyramine; oral

4.2

16.9

156

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.7

16.8

116

444

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

8.2

16.8

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

16.7

454

3031

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

3.3

16.7

265

L04

ICPC

Chest symptom/complaint

2.8

16.7

110

407

L11

ICPC

Wrist symptom/complaint

2.5

16.7

131

538

J01FA09

ATC

clarithromycin; systemic

1.6

16.7

521

3613

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.7

16.6

121

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

16.6

148

649

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

16.6

185

904

WX320

NOMESCO Finland

Spinalanesthesy

1.8

16.6

356

2219

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

8.0

16.6

A29

ICPC

General symptom/complaint other

2.2

16.5

183

894

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

5.7

16.5

N17

ICPC

Vertigo/dizziness

2.2

16.5

186

914

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.8

16.4

350

2174

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

7.0

16.4

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.8

16.4

109

408

N29

ICPC

Neurological sympt/complt other

5.0

16.3

106

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

4.1

16.3

161

RF210

NOMESCO Finland

4.0

16.3

166

K10.3

ICD-10 Finland

Alveolitis of jaws

3.3

16.3

265

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.2

16.2

174

838

SPAT1312

SPAT

General health counselling

1.6

16.2

531

3723

R10.0

ICD-10 Finland

Acute abdomen

3.9

16.2

172

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.7

16.1

114

441

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.7

16.1

110

416

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

16.1

122

494

C10AX09

ATC

ezetimibe; oral

2.2

16.0

176

855

N30.0

ICD-10 Finland

Acute cystitis

1.9

15.9

235

1291

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

15.9

265

1517

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

15.9

642

4735

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.7

15.9

109

415

XKC03

NOMESCO Finland

Water cystometry

3.9

15.8

176

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

15.8

188

947

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

15.7

237

1312

SBB10

NOMESCO Finland

Teeth copy

2.7

15.7

110

426

M19.9

ICD-10 Finland

Arthrosis, unspecified

3.6

15.7

208

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.3

15.7

251

R96

ICPC

Asthma

2.4

15.7

140

618

73398

ICD-8 Finland

Other diseases of muscle, tendon and fascia, Alii definiti

+∞

15.6

L18

ICPC

Muscle pain

3.6

15.6

198

D02

ICPC

Abdominal pain epigastric

2.8

15.6

104

389

N06AX12

ATC

bupropion; oral

2.6

15.6

118

475

N06AX26

ATC

vortioxetine; oral

2.7

15.6

111

432

K59.1

ICD-10 Finland

Functional diarrhoea

3.0

15.6

308

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

15.5

186

936

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

15.5

660

4917

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.1

15.5

186

938

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.6

15.5

119

485

G57.1

ICD-10 Finland

Meralgia paraesthetica

6.9

15.5

M23.8

ICD-10 Finland

Other internal derangements of knee

3.6

15.5

200

R06AX27

ATC

desloratadine; oral

1.6

15.4

440

2971

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

15.3

248

1405

R30.0

ICD-10 Finland

Dysuria

3.5

15.3

207

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

11.4

15.3

M54

ICD-10 Finland

Dorsalgia

2.1

15.2

190

973

D09

ICPC

Nausea

3.3

15.2

240

R03BA08

ATC

ciclesonide; inhalant

2.3

15.1

139

622

K04.0

ICD-10 Finland

Pulpitis

2.2

15.1

164

794

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.7

15.1

105

404

R51

ICD-10 Finland

Headache

2.8

15.0

363

R33

ICD-10 Finland

Retention of urine

2.5

15.0

118

486

N06AA12

ATC

doxepin; systemic

2.7

15.0

101

381

C01DA14

ATC

isosorbide mononitrate; oral

2.0

15.0

199

1048

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

9.5

14.9

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

32.0

14.8

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

5.0

14.8

AN1

Coronary angiography

2.1

14.8

170

842

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

14.8

149

695

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

14.8

304

1864

M22.4

ICD-10 Finland

Chondromalacia patellae

3.6

14.7

187

M35.7

ICD-10 Finland

Hypermobility syndrome

7.5

14.7

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

13.3

14.7

R31

ICD-10 Finland

Unspecified haematuria

2.2

14.7

153

724

R05FB02

ATC

cough suppressants and expectorants

1.5

14.7

596

4383

D07AD01

ATC

clobetasol; topical

1.8

14.7

262

1535

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.1

14.6

279

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

14.6

127

551

M02AA10

ATC

ketoprofen; topical

1.8

14.6

251

1450

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

7.1

14.6

M67.0

ICD-10 Finland

Short Achilles tendon (acquired)

80.7

14.6

G57.8

ICD-10 Finland

Other mononeuropathies of lower limb

14.3

14.5

ZXA10

NOMESCO Finland

Bilateral

1.8

14.5

292

1781

G58.0

ICD-10 Finland

Intercostal neuropathy

15.5

14.4

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

7.9

14.3

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

14.3

134

605

N03AG01

ATC

valproic acid; systemic, rectal

2.5

14.2

114

476

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.2

14.2

133

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

14.1

130

582

N05BA12

ATC

alprazolam; oral

2.0

14.1

182

948

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

14.0

112

466

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

14.0

299

RF421

NOMESCO Finland

12.8

13.9

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

3.4

13.8

203

H03AA01

ATC

levothyroxine sodium; systemic

1.6

13.8

386

2583

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

5.7

13.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

13.7

276

1679

R03BA01

ATC

beclometasone; inhalant

1.9

13.7

227

1295

E0000UV

ATC

1.5

13.7

627

4721

N06AB03

ATC

fluoxetine; oral

1.9

13.6

217

1223

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.6

13.6

174

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

13.6

266

1605

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

+∞

13.6

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.7

13.5

164

P01BA02

ATC

hydroxychloroquine; oral

2.2

13.5

138

648

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

13.5

178

935

I20.09

ICD-10 Finland

Unstable angina

2.7

13.5

343

N94.1

ICD-10 Finland

Dyspareunia

6.1

13.5

P29

ICPC

Psychological sympt/compl other

2.5

13.4

108

450

R12

ICD-10 Finland

Heartburn

2.3

13.4

123

550

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.5

13.4

181

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

12.9

13.4

SPAT1097

SPAT

Recording of ECG

1.8

13.4

231

1337

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

4.4

13.4

112

R07.0

ICD-10 Finland

Pain in throat

2.5

13.3

105

434

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.1

13.3

156

780

M70.7

ICD-10 Finland

Other bursitis of hip

4.4

13.3

108

U02

ICPC

Urinary frequency/urgency

1.9

13.3

201

1109

WX402

NOMESCO Finland

General anaesthesia

1.8

13.2

268

1634

9273

FHL

Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe

9.7

13.2

M19.8

ICD-10 Finland

Other specified arthrosis

3.6

13.2

168

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.9

13.1

198

1092

S63.5

ICD-10 Finland

Sprain and strain of wrist

3.4

13.1

195

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

12.2

13.1

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.8

13.1

321

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.3

13.1

201

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.2

13.1

212

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

3.6

13.1

164

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.7

13.0

154

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.7

13.0

154

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

13.0

235

1380

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

13.0

144

700

R74

ICPC

Upper respiratory infection acute

1.6

13.0

445

3123

M76.6

ICD-10 Finland

Achilles tendinitis

3.6

13.0

170

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.3

13.0

197

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

28.6

13.0

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

13.0

1150

9855

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

12.9

310

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

13.1

12.9

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

12.9

328

2136

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

12.8

289

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.5

12.8

103

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.5

12.7

101

419

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

6.1

12.7

SPAT1310

SPAT

Counselling related to known health issue

1.5

12.7

500

3626

P76

ICPC

Depressive disorder

2.4

12.7

112

490

J01MA12

ATC

levofloxacin; systemic

1.7

12.7

274

1699

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

7.5

12.7

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.1

12.7

123

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

12.7

394

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

12.7

155

789

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.2

12.7

137

661

SPAT1255

SPAT

Intravenous administration of medicine

2.3

12.7

113

500

F34.1

ICD-10 Finland

Dysthymia

3.2

12.6

212

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

4.5

12.6

100

C10AA07

ATC

rosuvastatin; oral

1.6

12.6

355

2375

J05AB11

ATC

valaciclovir; oral

1.8

12.5

215

1241

M01AC01

ATC

piroxicam; systemic, rectal

1.9

12.5

206

1172

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

12.5

294

1867

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

12.5

853

6922

RF420

NOMESCO Finland

5.0

12.5

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.2

12.5

203

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.1

12.5

231

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

12.5

114

510

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

130.8

12.4

NCL22

NOMESCO Finland

Myotomy or tenotomy of elbow or forearm

130.8

12.4

M43.1

ICD-10 Finland

Spondylolisthesis

3.2

12.4

209

M01AB01

ATC

indometacin; systemic, rectal

2.3

12.4

113

502

S49.9

ICD-10 Finland

Unspecified injury of shoulder and upper arm

5.5

12.4

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

7.7

12.4

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

6.9

12.4

WX419

NOMESCO Finland

Other general anesthesy

6.9

12.4

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.1

12.4

144

718

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

12.3

333

A06AC51

ATC

ispaghula, combinations; systemic

2.7

12.3

333

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

12.3

252

1538

C01CA24

ATC

epinephrine; parenteral

2.4

12.3

107

466

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

12.3

158

818

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

14.4

12.3

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

12.2

297

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

12.2

125

590

A05

ICPC

Feeling ill

2.5

12.2

402

J01CA08

ATC

pivmecillinam; oral

1.5

12.1

657

5088

RF120

NOMESCO Finland

5.5

12.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

12.1

151

776

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.4

12.1

100

C08CA01

ATC

amlodipine; oral

1.5

12.1

508

3732

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

8.2

12.1

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

8.2

12.1

Z01.9

ICD-10 Finland

Special examination, unspecified

2.4

12.1

100

426

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

12.0

165

G54.8

ICD-10 Finland

Other nerve root and plexus disorders

26.9

12.0

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.9

12.0

191

1072

1220

FHL

Arthroscopy

3.1

12.0

220

N02AJ13

ATC

tramadol and paracetamol; systemic

4.7

12.0

M24.2

ICD-10 Finland

Disorder of ligament

7.3

12.0

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

2.0

11.9

160

845

M75.2

ICD-10 Finland

Bicipital tendinitis

4.9

11.9

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

11.9

405

2834

A04

ICPC

Weakness/tiredness general

1.8

11.9

197

1122

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.6

11.9

358

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.4

11.9

167

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

11.9

369

2525

R03BA02

ATC

budesonide; inhalant

1.7

11.9

268

1682

J01MA14

ATC

moxifloxacin; systemic

2.1

11.9

136

673

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

11.9

404

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.4

11.8

173

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

11.8

142

716

U05

ICPC

Urination problems other

2.7

11.8

299

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

11.8

184

U01

ICPC

Dysuria/painful urination

2.2

11.8

124

592

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

11.8

122

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

4.2

11.7

103

SPAT1262

SPAT

Handing over of treatment supplies

1.7

11.7

276

1751

M75.5

ICD-10 Finland

Bursitis of shoulder

4.4

11.7

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

3.1

11.7

213

H66.9

ICD-10 Finland

Otitis media, unspecified

2.5

11.7

374

SPAT1284

SPAT

Extensive health certificate

3.3

11.7

175

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

4.8

11.7

D10

ICPC

Vomiting

2.4

11.6

402

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.4

11.6

422

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.6

11.6

349

TAD02

NOMESCO Finland

Sympathetic block of ganglion stellatum

65.3

11.6

R1250

NOMESCO Finland

Evaluation of functional capability

4.0

11.6

114

EBA10

NOMESCO Finland

Surgical removal of tooth

1.9

11.6

182

1019

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

8.2

11.6

Z00.8

ICD-10 Finland

Other general examinations

2.2

11.5

115

535

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.4

11.5

408

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.5

11.5

155

M75

ICD-10 Finland

Shoulder lesions

3.0

11.5

232

A03CA02

ATC

clidinium and psycholeptics; oral

2.3

11.5

102

449

S21

ICPC

Skin texture symptom/complaint

1.9

11.5

185

1044

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

10.1

11.5

C10AA01

ATC

simvastatin; oral

1.5

11.5

597

4571

73109

ICD-8 Finland

Synovitis, bursitis and tenosynovitis, Unspecified

+∞

11.5

WX892

NOMESCO Finland

Monitored bed care

2.2

11.5

120

573

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.6

11.4

346

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.6

11.4

146

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.1

11.4

139

705

N06AX05

ATC

trazodone; oral

3.7

11.4

136

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

11.4

117

554

S90.1

ICD-10 Finland

Contusion of toe(s) without damage to nail

4.8

11.3

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

4.2

11.3

102

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

4.2

11.3

102

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

7.0

11.3

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

11.3

236

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.0

11.2

217

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

11.2

390

ACC53

NOMESCO Finland

Release of ulnar nerve

6.3

11.2

C08DA01

ATC

verapamil; systemic

2.7

11.2

278

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.8

11.2

N03

ICPC

Pain face

8.1

11.1

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

8.1

11.1

M35.3

ICD-10 Finland

Polymyalgia rheumatica

3.1

11.0

194

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

11.0

117

563

R06AX22

ATC

ebastine; oral

1.6

11.0

281

1826

N76.0

ICD-10 Finland

Acute vaginitis

2.3

11.0

432

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.7

11.0

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

14.0

11.0

SPAT1283

SPAT

Restricted health certificate

1.7

11.0

270

1735

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

2.9

11.0

229

N41.1

ICD-10 Finland

Chronic prostatitis

4.1

10.9

101

N02AA01

ATC

morphine; systemic, rectal

6.3

10.9

N03AX11

ATC

topiramate; oral

3.4

10.9

157

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

10.9

120

584

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.5

10.9

327

SPAT1106

SPAT

Acupuncture

7.8

10.9

1410

FHL

Laparoscopy

3.5

10.9

147

R60.9

ICD-10 Finland

Oedema, unspecified

2.7

10.8

278

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

15.6

10.8

NF3AA

NOMESCO Finland

Femur X-ray examination

4.6

10.8

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

10.8

379

G44.8

ICD-10 Finland

Other specified headache syndromes

5.4

10.7

G44.0

ICD-10 Finland

Cluster headache syndrome

5.4

10.7

L19

ICPC

Muscle symptom/complaint NOS

3.8

10.7

118

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

4.6

10.7

UDC00

NOMESCO Finland

Ear microscopy

2.1

10.7

121

598

N40

ICD-10 Finland

Hyperplasia of prostate

1.7

10.7

233

1446

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.9

10.6

163

903

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

2.1

10.6

116

564

B01AC04

ATC

clopidogrel; oral

1.8

10.6

205

1229

G04BD12

ATC

mirabegron; oral

1.9

10.6

149

799

H29

ICPC

Ear symptom/complaint other

1.9

10.6

151

817

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.6

10.5

306

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

10.5

204

1221

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.9

10.5

C07AB02

ATC

metoprolol; systemic

1.6

10.5

282

1854

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

10.1

10.5

R06.4

ICD-10 Finland

Hyperventilation

4.6

10.5

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.9

10.5

212

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

5.1

10.5

M79.5

ICD-10 Finland

Residual foreign body in soft tissue

5.4

10.4

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

5.4

10.4

M24.4

ICD-10 Finland

Recurrent dislocation and subluxation of joint

5.9

10.4

G54.3

ICD-10 Finland

Thoracic root disorders, not elsewhere classified

+∞

10.4

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

5.6

10.4

H53.2

ICD-10 Finland

Diplopia

3.3

10.4

163

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.4

10.4

147

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.2

10.4

105

494

SPAT1058

SPAT

PEF monitoring instruction

2.1

10.4

121

605

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.6

10.4

292

N07CA01

ATC

betahistine; oral

2.1

10.3

110

530

R06.2

ICD-10 Finland

Wheezing

2.6

10.3

293

A02BA04

ATC

nizatidine; systemic

2.1

10.3

114

558

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.7

10.3

269

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

5.5

10.3

Z56.7

ICD-10 Finland

Other and unspecified problems related to employment

18.9

10.3

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.8

10.3

G57.0

ICD-10 Finland

Lesion of sciatic nerve

23.5

10.2

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.0

10.2

139

739

M77.9

ICD-10 Finland

Enthesopathy, unspecified

3.6

10.2

128

X57

ICD-10 Finland

Unspecified privation

4.0

10.2

M62.6

ICD-10 Finland

Muscle strain

3.6

10.2

123

W17

ICD-10 Finland

Other fall from one level to another

2.7

10.2

264

U07

ICPC

Urine symptom/complaint other

2.3

10.2

416

M10.9

ICD-10 Finland

Gout, unspecified

2.3

10.2

395

S97

ICPC

Chronic ulcer skin

2.4

10.1

347

R07

ICPC

Sneezing/nasal congestion

2.2

10.1

100

464

B01AF01

ATC

rivaroxaban; oral

1.8

10.1

166

945

C09CA06

ATC

candesartan; oral

1.6

10.1

319

2185

A46

ICD-10 Finland

Erysipelas

1.8

10.1

192

1146

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

10.0

131

684

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.6

10.0

295

F32.1

ICD-10 Finland

Moderate depressive episode

2.2

10.0

445

S61.8

ICD-10 Finland

Open wound of other parts of wrist and hand

3.6

10.0

125

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

10.1

10.0

G56.8

ICD-10 Finland

Other mononeuropathies of upper limb

10.1

10.0

C08CA05

ATC

nifedipine; systemic

2.2

10.0

447

S20.2

ICD-10 Finland

Contusion of thorax

2.6

10.0

297

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

7.3

10.0

N92

ICPC

Trigeminal neuralgia

40.3

10.0

M76.0

ICD-10 Finland

Gluteal tendinitis

5.6

10.0

S01

ICPC

Pain/tenderness of skin

2.6

10.0

280

S04

ICPC

Lump/swelling localized

1.9

9.9

142

766

ZA1.0

ICD-10 Finland

Shoulder region

4.0

9.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

9.9

138

738

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.7

9.9

239

R68.2

ICD-10 Finland

Dry mouth, unspecified

7.7

9.9

9476

FHL

Splitting of fascia or aponeurosis

16.8

9.9

A10AE04

ATC

insulin glargine; parenteral

1.9

9.9

138

742

TQW99

NOMESCO Finland

Other minor procedure on skin

2.4

9.8

358

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

9.8

190

1138

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.5

9.8

320

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

4.4

9.8

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3.1

9.8

165

NH1AD

NOMESCO Finland

Ankle and foot CT

3.8

9.8

107

G43.3

ICD-10 Finland

Complicated migraine

4.3

9.8

M01AB08

ATC

etodolac; oral

2.1

9.8

112

555

D12

ICPC

Constipation

3.0

9.7

183

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

9.7

460

R07.2

ICD-10 Finland

Precordial pain

3.9

9.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

9.7

105

509

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

9.7

200

1220

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

9.7

175

1026

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.8

9.7

230

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

9.7

140

761

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.8

9.7

S22

ICPC

Nail symptom/complaint

2.3

9.6

420

N30.9

ICD-10 Finland

Cystitis, unspecified

2.3

9.6

388

N07BA03

ATC

varenicline; oral

2.3

9.6

389

E66.8

ICD-10 Finland

Other obesity

2.3

9.6

370

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.5

9.6

125

R40.0

ICD-10 Finland

Somnolence

15.1

9.5

F43.00

ICD-10 Finland

Acute stress reaction mild

3.4

9.5

131

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

9.5

180

1074

N80.9

ICD-10 Finland

Endometriosis, unspecified

4.0

9.4

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

9.4

134

723

R04.2

ICD-10 Finland

Haemoptysis

3.0

9.4

186

N02AA03

ATC

hydromorphone; systemic, rectal

30.2

9.4

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

30.2

9.4

G58.8

ICD-10 Finland

Other specified mononeuropathies

17.6

9.4

M79.8

ICD-10 Finland

Other specified soft tissue disorders

17.6

9.4

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

17.6

9.4

W10

ICD-10 Finland

Fall on and from stairs and steps

2.4

9.4

316

AXX90

NOMESCO Finland

Intravascular test of medication against pain

+∞

9.4

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

9.4

306

2110

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

5.9

9.4

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

908

4619

2.75

105.04

3.5

2.4

u/l

52.7

59.6

6.30

857

4259

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

839

4151

2.74

101.83

2.7

2.0

u/l

187.1

267.4

1.14

790

3881

(3013826) Glucose [Moles/volume] in Serum or Plasma

1396

8990

2.76

97.64

6.5

4.4

mmol/l

6.6

6.7

0.44

1346

8317

(3013707) Erythrocyte sedimentation rate by Westergren method

1635

11579

3.10

92.63

5.3

3.6

mm/h

11.8

11.9

0.12

1558

10697

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

980

5437

2.55

91.52

5.2

3.2

ng/l

28.9

59.3

1.22

683

3478

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1202

7437

2.51

87.22

8.2

6.6

mmol/l

1.2

0.66

1046

6262

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1262

8044

2.50

84.88

6.9

6.2

umol/l

9.7

11.4

9.73

1220

7632

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1664

12185

3.01

82.92

9.5

7.2

u/l

74.9

77.8

2.72

1599

11471

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

651

3107

2.61

81.55

1.9

1.7

mg/l

1.0

1.3

1.79

493

2325

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1093

6703

2.36

77.58

7.3

5.8

mmol/l

1.2

0.89

1009

6069

(3032080) INR in Blood by Coagulation assay

994

5921

2.33

74.59

10.4

8.4

inr

1.2

1.18

304

1737

(3006315) Basophils [#/volume] in Blood

1178

7768

2.23

66.28

6.7

5.6

e9/l

0.0

0.59

1062

6665

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

522

2452

2.52

65.60

1.4

1.2

iu/ml

29.0

33.1

0.30

173

787

(42870588) Differential panel, method unspecified - Blood

874

5137

2.23

65.27

6.5

5.7

—

(3001604) Monocytes [#/volume] in Blood

1170

7738

2.21

64.75

6.6

5.6

e9/l

0.6

1.11

1060

6645

(3023368) Bacteria identified in Blood by Culture

710

3860

2.29

63.81

4.7

4.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1479

10799

2.36

63.62

6.0

3.9

—

(3013115) Eosinophils [#/volume] in Blood

1200

8053

2.20

63.52

6.9

5.9

e9/l

0.2

0.58

1086

7017

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

875

5228

2.18

61.83

3.9

3.1

u/l

31.7

32.3

0.16

843

4991

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

490

2294

2.50

61.57

1.3

1.2

u/ml

4.7

12.1

2.96

176

917

(3019198) Lymphocytes [#/volume] in Blood

1182

7983

2.15

60.25

6.8

5.7

e9/l

2.0

1.9

0.18

1080

6986

(3022096) Basophils/100 leukocytes in Blood

1086

7106

2.13

60.09

6.8

5.8

0.7

0.98

1033

6614

(3031040) Bacteria [#/volume] in Urine by Automated count

1415

10266

2.24

59.86

6.3

4.0

e6/l

213.6

2598.9

2.54

146

(3006504) Eosinophils/100 leukocytes in Blood

1108

7323

2.13

59.50

6.8

5.7

2.8

0.04

1056

6815

(3024561) Albumin [Mass/volume] in Serum or Plasma

1027

6614

2.12

58.84

5.4

4.8

g/l

35.7

35.8

0.12

963

6175

(3019069) Monocytes/100 leukocytes in Blood

1110

7368

2.12

58.60

7.2

6.0

8.4

8.5

0.58

1055

6888

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

694

3877

2.20

57.12

3.0

ng/l

963.8

1304.4

2.12

599

3285

(3018010) Neutrophils/100 leukocytes in Blood

1118

7499

2.09

56.69

6.8

5.6

56.8

57.3

0.69

1063

7017

(3002030) Lymphocytes/100 leukocytes in Blood

1129

7606

2.09

56.50

7.0

5.8

28.3

28.1

0.21

1075

7089

(3013650) Neutrophils [#/volume] in Blood by Automated count

1294

9194

2.12

55.85

9.5

9.2

e9/l

4.1

0.49

1185

7994

(3037522) Nuclear Ab [Titer] in Serum

419

1905

2.51

55.48

1.5

1.3

titre

673.0

537.3

0.50

394

(3048689) Calprotectin [Mass/mass] in Stool

401

1820

2.50

53.09

2.5

2.4

ug/g

112.7

134.8

0.69

324

1457

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1085

7365

2.01

51.29

4.9

3.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

321

1336

2.67

50.69

2.2

2.1

nmol/l

356.4

383.9

1.68

300

1225

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

257

961

2.92

49.75

2.7

2.3

au/ml

5.5

21.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1914

16441

3.80

49.16

22.5

12.1

mg/l

20.1

24.2

7.20

1678

12661

(3008152) Bicarbonate [Moles/volume] in Arterial blood

238

873

2.96

47.63

7.6

7.7

mmol/l

24.8

24.6

0.33

224

808

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1593

12602

2.22

47.50

4.9

3.9

pmol/l

14.7

0.19

1485

11504

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

527

2808

2.18

47.44

4.4

3.4

ng/l

154.6

517.1

3.51

376

2123

(3042936) Bacteria identified in Isolate by Culture

406

1948

2.35

47.01

2.4

2.0

—

(3026008) Bacteria identified in Urine by Culture

734

4458

2.01

46.33

3.8

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

923

6072

1.95

46.15

2.2

1.9

pmol/l

95.1

95.5

0.09

488

3108

(3047181) Lactate [Moles/volume] in Blood

156

455

3.63

45.43

6.4

8.5

mmol/l

1.2

1.3

0.76

144

394

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

448

2309

2.21

43.37

2.1

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

352

1649

2.37

42.72

2.1

1.6

—

(40768797) Stomach Pathology biopsy report

406

2022

2.26

42.69

1.3

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1929

16955

3.69

41.34

23.6

13.9

mmol/l

139.5

139.7

2.83

1914

16500

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1789

15132

2.52

41.19

5.9

4.6

mu/l

1.8

2.1

1.81

1676

13888

(3018418) pH of Serum or Plasma

711

4430

1.93

40.46

4.7

3.9

7.4

0.39

128

833

(3019150) Specific gravity of Urine by Refractometry

560

3222

2.02

40.12

6.0

3.8

kg/l

1.0

2.29

124

470

(3023103) Potassium [Moles/volume] in Serum or Plasma

1929

17017

3.61

39.79

23.7

14.0

mmol/l

4.0

1.85

1913

16523

(3003396) Base excess in Arterial blood by calculation

343

1642

2.31

39.37

8.0

8.1

mmol/l

1.4

1.1

0.91

260

1293

(3035350) Ketones [Presence] in Urine by Test strip

1063

7578

1.84

39.23

5.0

3.3

estimate

0.0

0.00

187

1356

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

577

3389

1.98

38.78

1.4

1.2

u/ml

0.8

1.5

2.66

141

890

(3019060) Gas panel - Arterial blood

229

918

2.68

38.48

5.8

5.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1063

7608

1.83

38.44

6.6

4.6

estimate

0.0

0.50

195

1390

(3009261) Glucose [Presence] in Urine by Test strip

1071

7701

1.83

37.96

5.1

3.4

estimate

0.0

0.40

191

1351

(3016502) Oxygen saturation in Arterial blood

307

1431

2.35

37.36

8.4

8.8

96.1

95.9

0.28

293

1379

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

339

1650

2.27

37.26

8.1

kpa

5.2

5.1

0.87

318

1574

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

937

6495

1.82

37.24

2.7

2.2

nmol/l

76.3

77.2

0.39

868

5877

(3002173) Hemoglobin [Mass/volume] in Arterial blood

293

1343

2.38

37.03

8.7

9.2

g/l

122.4

0.02

280

1286

(3027801) Oxygen [Partial pressure] in Arterial blood

337

1650

2.25

36.46

8.1

kpa

12.2

12.6

0.72

317

1573

(3019309) Folate [Moles/volume] in Red Blood Cells

463

2587

2.02

35.42

1.8

1.7

nmol/l

1200.8

1131.2

0.91

367

1933

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

164

575

3.01

35.31

6.0

7.0

1.9

1.6

1.68

158

535

(3039000) Anion gap in Blood

115

324

3.70

35.16

7.1

10.3

mmol/l

11.7

11.3

0.41

108

287

(3018572) Chloride [Moles/volume] in Blood

115

324

3.70

35.16

7.1

10.3

mmol/l

104.9

105.1

0.17

108

287

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

601

3697

1.89

34.50

2.5

2.1

mg/l

2.7

2.9

1.56

526

3127

(3007930) Methemoglobin/Hemoglobin.total in Blood

160

568

2.97

33.68

6.2

7.1

0.9

0.29

154

526

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

234

1013

2.48

33.39

1.9

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

321

1601

2.19

32.96

2.0

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

548

3321

1.89

32.66

1.6

1.5

nmol/l

19.8

20.9

0.91

483

2849

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

319

1610

2.16

31.72

2.1

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

407

2253

2.01

31.58

2.7

2.4

umol/l

12.8

13.5

1.18

372

2093

(3015171) Extractable nuclear Ab [Units/volume] in Serum

148

529

2.94

30.74

1.4

1.2

u/ml

0.2

1.3

1.14

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

332

1724

2.11

30.59

2.9

2.5

umol/l

5.8

8.2

2.31

286

1492

(3012095) Magnesium [Moles/volume] in Serum or Plasma

426

2426

1.96

30.34

3.4

3.5

mmol/l

0.8

0.54

393

2275

(3001122) Ferritin [Mass/volume] in Serum or Plasma

956

6946

1.71

30.08

3.4

2.7

ug/l

117.7

120.7

0.16

894

6440

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

119

380

3.26

29.97

1.5

1.2

u/ml

42.6

50.1

—

(3029937) Albumin [Presence] in Urine by Test strip

619

3989

1.79

29.77

5.8

3.7

estimate

0.0

0.80

189

1347

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

835

5869

1.72

29.51

5.5

3.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1373

11046

1.75

29.37

4.2

2.9

u/l

53.5

47.0

1.14

1300

10328

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

188

779

2.56

29.33

10.2

12.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

396

2226

1.97

29.19

2.0

2.1

29.7

29.6

0.13

367

2157

(3005719) IgG [Mass/volume] in Serum or Plasma

242

1127

2.30

29.16

2.6

2.9

g/l

10.1

10.7

1.08

234

1013

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

115

367

3.26

28.99

1.4

1.3

mg/l

488.1

507.3

0.16

110

346

(3007164) IgA [Mass/volume] in Serum or Plasma

493

2987

1.86

28.90

1.7

1.4

g/l

2.3

2.4

0.48

293

1872

(3044640) Blood type and Crossmatch panel - Blood

725

4955

1.72

28.01

2.8

2.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

372

2075

1.97

27.93

2.7

2.4

g/l

2.4

2.3

0.23

345

1915

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

121

408

3.09

27.82

1.8

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

232

1086

2.28

27.57

2.7

2.9

g/l

66.8

66.5

0.23

212

992

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

103

320

3.34

27.11

1.3

mmol/l

3.7

3.8

0.19

299

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1946

17793

3.19

27.02

23.9

14.1

umol/l

75.5

75.0

0.25

1946

17787

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

350

1932

1.98

27.01

2.7

2.5

21.8

23.5

1.39

261

1665

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

762

5328

1.69

26.76

3.7

3.0

—

(3002582) Erythrocytes [#/volume] in Urine

667

4502

1.72

26.69

3.4

2.9

e6/l

58.5

93.6

0.51

542

3396

(3026782) Osmolality of Urine

470

2881

1.82

26.20

2.6

2.5

mosm/kgh2o

515.5

553.2

3.18

382

2430

(3044889) 12 lead EKG panel

1395

11443

1.70

25.98

4.0

3.4

—

(3000850) Epithelial cells [#/volume] in Urine

489

3047

1.80

25.76

2.6

2.4

e6/l

6.0

6.3

0.17

426

2640

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

112

5.02

25.63

1.2

mg/l

67.6

40.9

0.34

(3015377) Calcium [Moles/volume] in Serum or Plasma

754

5306

1.67

25.54

3.4

3.5

mmol/l

2.3

2.4

2.69

670

4693

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

106

350

3.14

25.25

1.5

1.3

u/ml

9.5

9.1

0.03

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

508

3227

1.77

24.95

1.8

1.6

pmol/l

181879616.7

24596020.0

1.87

447

2720

(3044290) Cell count panel - Cerebral spinal fluid

296

3.28

24.22

1.8

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

104

349

3.09

24.11

1.5

1.2

u/ml

4.6

2.7

—

(3009343) pH of Capillary blood

179

793

2.38

24.07

3.9

3.7

7.4

0.35

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

173

758

2.40

23.85

3.9

3.7

mmol/l

1.7

1.8

0.08

129

564

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

289

3.29

23.80

1.5

1.2

u/ml

29.8

32.6

0.09

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

180

804

2.36

23.76

3.9

3.7

kpa

5.2

5.1

0.19

171

740

(3033658) Prothrombin time (PT) actual/Normal

597

4020

1.69

23.52

4.1

3.6

95.1

91.9

2.35

570

3917

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

105

4.96

23.48

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1714

15057

1.88

23.46

6.3

5.1

mmol/mol

39.9

39.2

2.50

1606

13961

(36304419) Bacteria [Presence] in Urine

597

4024

1.68

23.41

3.3

2.8

—

(36660697) Celiac disease serology panel - Serum

238

1202

2.11

23.26

1.2

—

(40761511) CBC panel - Blood by Automated count

1907

17438

2.51

23.11

21.3

11.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

259

3.38

23.08

1.8

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

194

911

2.25

22.76

2.9

2.5

—

(3018095) Leukocytes [#/volume] in Urine

745

5344

1.62

22.72

4.1

3.3

e6/l

72.5

106.7

0.76

577

3671

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

115

424

2.81

22.53

1.6

1.7

g/l

1.2

0.46

109

392

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1934

17831

2.74

22.48

13.9

9.5

u/l

25.8

26.1

0.35

1892

17194

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

112

409

2.84

22.34

1.6

1.7

g/l

0.2

0.04

107

376

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

323

3.07

22.16

1.8

1.4

e6/l

742.4

426.6

0.22

263

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

323

3.07

22.16

1.8

1.3

e6/l

9.0

39.9

0.91

243

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

142

588

2.52

22.10

1.8

1.9

—

(3022621) pH of Urine by Test strip

202

976

2.19

22.08

5.0

2.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

107

388

2.86

21.62

1.6

1.4

ug/g

304.1

290.2

0.21

222

(3002385) Erythrocyte distribution width [Ratio]

1610

13995

1.72

21.39

24.4

15.1

13.7

13.6

0.70

1603

13642

(3009508) Creatinine [Moles/volume] in Urine

658

4662

1.61

20.67

3.1

mmol/l

7.3

7.6

0.79

550

3933

(3026493) Urate [Moles/volume] in Serum or Plasma

556

3793

1.64

20.31

3.0

2.6

umol/l

1491.0

7095.8

5.14

484

3324

(3011397) Hemoglobin [Presence] in Urine by Test strip

520

3489

1.66

20.27

4.9

3.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

144

638

2.35

19.32

2.0

u/l

38.7

38.8

0.03

126

573

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

279

1593

1.87

19.03

3.6

4.6

u/l

240.4

243.5

0.09

257

1515

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1746

15669

1.81

19.03

17.9

11.4

ml/min/173m2

83.3

82.5

0.68

1445

12792

(3041096) Erythrocytes [Presence] in Urine by Automated

598

4214

1.59

18.88

4.5

3.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

5.53

18.86

1.1

1.2

u/l

443.4

454.7

0.02

(3030467) Casts [#/volume] in Urine by Automated count

586

4116

1.60

18.73

3.3

2.8

e6/l

0.3

0.5

3.99

466

3053

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

220

1173

1.98

18.40

2.8

2.9

ng/l

162.4

185.3

0.37

202

1053

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

266

3.05

18.24

1.5

1.2

u/ml

1.3

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1776

16075

1.83

18.06

4.8

4.2

mmol/l

6.0

5.9

2.84

1655

14691

(3005322) IgE [Units/volume] in Serum or Plasma

189

964

2.06

17.87

1.4

1.2

u/ml

163.4

219.3

0.53

176

877

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

206

1084

2.00

17.87

3.5

3.7

ng/l

82.1

87.4

0.24

177

940

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

5.57

17.45

1.6

1.5

u/l

5.8

6.2

0.23

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

4.88

17.33

1.1

u/l

1.2

0.03

(3000494) Fungus identified in Specimen by Culture

289

1729

1.78

16.83

1.6

1.4

—

(3013512) EKG study

592

4254

1.55

16.81

4.8

3.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

152

732

2.16

16.69

2.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

124

551

2.33

16.53

2.2

2.1

ug/l

2.2

1.8

0.20

103

484

(3003327) Ova and parasites identified in Stool by Light microscopy

108

451

2.47

16.52

1.6

1.7

—

(4010399)

195

1036

1.98

16.44

1.5

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

160

791

2.11

16.43

1.8

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

102

419

2.51

16.16

4.6

3.4

mmol/l

3.8

0.11

394

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1272

10749

1.49

16.11

3.4

2.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

427

2871

1.62

16.02

1.7

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

106

447

2.45

15.88

1.7

1.6

titre

510.0

457.5

—

(40768804) Tissue Pathology biopsy report

847

6623

1.48

15.82

2.2

2.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

248

1444

1.82

15.76

2.8

2.2

u/l

52.5

43.3

0.17

203

1244

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

107

455

2.43

15.74

2.0

2.2

ug/l

231.3

1093.7

1.19

430

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

192

1032

1.95

15.63

2.8

3.3

pmol/l

4.4

4.5

0.78

170

936

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

130

3.76

15.61

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

203

1113

1.92

15.58

2.3

2.8

e9/l

72.9

68.5

0.82

154

818

(3025941) Bacteria identified in Stool by Culture

164

835

2.05

15.56

1.4

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

282

1715

1.75

15.45

21.7

22.0

inr

1.4

1.3

0.37

241

(3003458) Phosphate [Moles/volume] in Serum or Plasma

304

1893

1.71

15.30

6.3

5.9

mmol/l

1.0

0.49

284

1752

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

160

813

2.05

15.26

1.9

1.5

—

(4027681)

4.28

14.82

1.2

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

227

1313

1.82

14.71

4.3

3.3

kpa

5.9

5.8

0.94

217

1274

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

295

2.71

14.62

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

378

2.50

14.59

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

144

720

2.08

14.35

2.9

2.7

e6/l

0.1

0.3

2.12

138

698

(3002032) Base excess in Venous blood by calculation

225

1309

1.81

14.30

4.4

3.3

mmol/l

1.9

0.01

185

1052

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

445

2.36

14.19

2.4

1.9

—

(3012516) Albumin [Mass/volume] in Urine

588

4354

1.49

14.03

3.1

3.2

mg/l

1246.7

404.5

1.55

361

2687

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

240

2.85

13.92

1.4

1.3

—

36.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

288

1811

1.69

13.91

7.6

7.0

mmol/l

104.5

104.4

0.11

280

1770

(3016018) Differential panel - Cerebral spinal fluid

146

3.41

13.86

2.2

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

191

1067

1.87

13.82

4.0

2.6

kpa

4.5

4.7

1.03

185

1033

(3008898) HLA-B27 [Presence]

108

489

2.28

13.80

1.1

1.0

—

(3022145) Colonoscopy Study observation

277

1729

1.70

13.74

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

154

802

2.00

13.72

1.1

1.0

—

(3017181) Myelocytes/100 leukocytes in Blood

216

1260

1.80

13.59

4.1

4.2

1.1

0.9

0.56

342

(3011288) Drugs identified in Urine by Screen method

381

2.43

13.40

2.6

3.0

—

(40758558) Short blood count panel - Blood

546

4019

1.49

13.30

6.1

6.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

106

484

2.26

13.29

4.8

3.9

mmol/l

25.0

0.00

448

(3028026) IgM [Mass/volume] in Serum or Plasma

164

883

1.93

13.27

2.3

1.8

g/l

1.6

1.5

0.13

152

799

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

121

3.61

13.27

1.7

1.5

44.2

56.6

1.15

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

105

479

2.26

13.19

2.8

2.2

g/l

9.5

10.5

1.18

409

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

206

1197

1.80

13.12

2.4

2.2

ug/l

5.3

8.2

1.42

173

1058

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

241

1468

1.73

13.04

2.2

2.1

g/l

0.2

0.19

224

1370

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

366

2480

1.58

13.04

3.0

2.5

e6/l

1.0

1.2

0.58

226

1372

(3024731) MCV [Entitic volume]

1969

18774

2.55

12.96

30.9

18.0

91.1

90.9

1.29

1963

18495

(3035941) MCH [Entitic mass]

1969

18775

2.55

12.94

30.9

17.9

30.3

0.41

1963

18493

(3020682) Albumin/Creatinine [Ratio] in Urine

606

4576

1.46

12.90

3.7

3.9

mg/mmol

7.9

8.6

0.16

361

2850

(3026361) Erythrocytes [#/volume] in Blood

1969

18778

2.54

12.88

31.0

18.0

e12/l

4.4

4.5

5.17

1949

18214

(3007461) Platelets [#/volume] in Blood

1968

18765

2.53

12.86

31.1

18.0

e9/l

257.9

254.3

1.67

1953

18257

(3000475) Leukocytes [#/volume] in Synovial fluid

274

2.65

12.82

1.7

1.6

e6/l

7063.8

11894.6

0.71

198

(3010813) Leukocytes [#/volume] in Blood

1969

18782

2.54

12.80

31.1

18.1

e9/l

7.0

6.7

4.54

1951

18220

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.15

12.77

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1969

18787

2.53

12.70

31.2

18.1

g/l

134.1

135.5

4.36

1962

18506

(3013139) Helicobacter pylori Ag [Presence] in Stool

176

984

1.86

12.69

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

417

2.31

12.62

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

420

2.30

12.41

1.2

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

123

615

2.06

12.27

5.9

3.3

52.4

49.9

0.55

123

606

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

179

3.01

12.25

1.2

1.3

nmol/l

—

(3025159) Blasts/100 leukocytes in Blood

194

1133

1.79

12.14

4.2

4.3

0.0

0.4

0.62

261

(42529406) Shigella sp [Presence] in Stool by Culture

425

2.27

12.08

1.2

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

451

2.23

12.07

1.7

1.6

iu/ml

5.1

0.1

0.66

(3015235) Bicarbonate [Moles/volume] in Capillary blood

331

2.44

12.06

2.5

3.4

mmol/l

24.6

25.0

0.38

285

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

506

3736

1.47

11.94

3.0

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

276

1784

1.63

11.89

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

195

1149

1.77

11.83

4.0

0.9

0.6

0.45

246

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

5.40

11.83

1.1

1.0

—

(3019225) pH of Specimen

230

1420

1.70

11.82

5.1

4.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

118

590

2.06

11.78

1.1

—

0.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

417

2.26

11.76

4.5

3.6

mg/l

42.7

57.0

0.46

336

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

417

2.26

11.76

4.5

3.6

mg/l

29.3

87.3

1.09

339

(3035637) Corticotropin [Mass/volume] in Plasma

168

3.03

11.68

1.3

1.5

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

513

2.12

11.53

2.8

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

513

2.12

11.53

2.8

2.2

g/l

3.5

3.9

2.60

376

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

106

513

2.12

11.53

2.8

2.2

g/l

7.4

0.02

390

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

341

2334

1.55

11.52

3.0

2.7

e6/l

3.4

3.0

0.24

203

1233

(3022313) Gas panel - Capillary blood

115

575

2.06

11.48

4.5

3.7

—

(3021901) Oxygen saturation in Capillary blood

237

2.67

11.44

2.5

3.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

114

3.47

11.40

1.6

1.4

promille

1.1

1.3

0.25

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

486

2.13

11.16

2.8

2.2

g/l

3.0

3.1

0.77

385

(3021440) Promyelocytes/100 leukocytes in Blood

198

1194

1.73

11.08

4.2

4.3

0.0

0.1

4.81

313

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

3.97

11.03

1.0

1.1

nmol/l

0.2

5.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

244

1558

1.64

11.01

2.5

2.7

1.8

0.26

210

1384

(3010144) Erythrocytes [#/volume] in Synovial fluid

107

3.50

11.00

1.4

1.3

e6/l

223280.9

91823.7

0.25

(3016879) Cocaine [Presence] in Urine

107

532

2.07

10.86

2.4

2.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

155

878

1.83

10.72

4.0

2.7

g/l

129.4

130.1

0.14

146

852

(3028707) Methadone [Presence] in Urine by Screen method

240

2.59

10.65

2.9

2.7

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

101

3.51

10.45

1.6

2.7

e6/l

600.2

523.4

0.31

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

107

541

2.03

10.38

2.3

2.0

u/l

11175.6

3316.6

0.90

222

(3004616) Nuclear Ab [Presence] in Serum

164

2.91

10.31

1.5

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

203

1257

1.68

10.30

8.1

7.2

mmol/l

1.3

0.00

197

1216

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

314

2.34

10.10

1.4

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

134

3.10

10.07

2.4

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

309

2.34

10.01

4.6

3.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

136

3.06

9.83

1.1

1.2

—

(4198724)

4.40

9.80

3.5

1.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

132

3.07

9.68

1.4

g/l

2.5

2.8

0.69

(3024139) IgG subclass 3 [Mass/volume] in Serum

132

3.07

9.68

1.4

g/l

0.3

0.4

0.13

(3023323) Follitropin [Units/volume] in Serum or Plasma

144

827

1.80

9.54

1.5

1.3

iu/l

24.1

28.8

1.09

122

704

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

289

1984

1.53

9.53

2.1

1.7

1.5

1.4

0.84

253

1763

(3027273) Bicarbonate [Moles/volume] in Venous blood

123

674

1.88

9.47

4.8

3.0

mmol/l

25.7

25.3

0.66

117

655

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

207

2.60

9.42

1.2

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

467

3530

1.42

9.42

5.1

4.5

—

(3021589) Normoblasts [#/volume] in Blood

857

7146

1.34

9.41

10.9

8.6

e9/l

0.0

0.12

712

5837

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.25

9.38

1.3

1.4

umol/l

106.0

216.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

+∞

9.38

2.2

0.0

mmol/l

4.1

—

(4062490)

135

3.00

9.32

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1681

15571

1.46

9.28

23.0

13.4

39.4

39.8

0.92

1179

11600

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

210

2.56

9.16

1.2

1.3

nmol/l

0.5

—

(3017732) Neutrophils [#/volume] in Blood

172

1052

1.69

9.14

3.8

2.8

e9/l

3.9

4.1

0.49

130

845

(3023511) Choriogonadotropin [Units/volume] in Urine

303

2.29

9.11

2.0

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

3.79

9.06

1.1

1.5

nmol/l

1.5

4.4

0.88

(1616796) Gas panel - Central venous blood

279

2.34

9.02

2.6

3.6

—

(3023410) Appearance of Cerebral spinal fluid

138

2.94

8.99

2.5

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.73

8.89

1.2

—

(3011412) CD3 cells [#/volume] in Blood

150

2.84

8.87

1.8

2.5

e9/l

1.4

1.2

0.49

(3024980) IgG subclass 4 [Mass/volume] in Serum

221

2.48

8.75

1.4

1.7

g/l

0.6

0.9

0.74

163

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

6.04

8.65

1.3

51.3

34.6

—

(3051593) INR in Capillary blood by Coagulation assay

3.97

8.60

6.0

11.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

523

1.94

8.53

2.3

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

474

1.99

8.52

3.5

2.8

—

(3042517) Benzodiazepines panel - Urine

8.50

8.46

1.3

—

(3044927) Protein electrophoresis panel - Urine

127

2.95

8.40

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

244

2.37

8.39

1.5

1.7

—

(3049717) Cytology report of Urine Cyto stain

512

1.94

8.38

2.2

2.6

—

(40768443) Skin Pathology biopsy report

114

635

1.84

8.36

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

3.26

8.35

1.3

1.1

—

4.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

409

2.05

8.31

2.7

1.8

g/l

38.3

37.5

0.54

357

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

106

579

1.88

8.27

2.4

1.9

—

(3038026) Centromere Ab [Units/volume] in Serum

102

3.17

8.24

1.3

1.1

—

45.5

—

(3028300) Cannabinoids [Presence] in Urine

108

595

1.86

8.21

2.4

2.0

—

(3037121) Protein [Mass/volume] in Urine

497

1.93

8.09

3.1

3.5

g/l

0.2

0.01

207

(3020891) Body temperature

100

541

1.89

8.04

5.4

4.0

—

(3000764) Benzodiazepines [Presence] in Urine

107

592

1.85

8.03

2.4

2.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

143

2.76

7.88

7.2

6.7

mmol/l

7.3

0.03

125

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

105

3.08

7.86

1.3

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

304

2.18

7.80

2.1

2.3

g/l

138.1

130.3

2.00

219

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1787

16871

1.49

7.80

5.3

4.5

mmol/l

2.8

2.46

1676

15597

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

440

1.97

7.79

3.2

2.1

g/l

0.6

1.2

0.66

383

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

117

674

1.78

7.71

3.6

3.5

mmol/l

24.2

24.1

0.11

101

618

(3037756) Immunofixation for Serum or Plasma

293

2.19

7.67

1.8

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

180

1166

1.60

7.64

1.2

iu/ml

85.7

147.8

1.74

451

(3009214) Lutropin [Units/volume] in Serum or Plasma

417

1.98

7.55

1.3

1.4

u/l

10.2

9.8

0.10

338

(3020779) Urea [Moles/volume] in Serum or Plasma

190

1251

1.57

7.52

8.6

7.9

mmol/l

9.3

9.6

0.12

181

1192

(3027008) Opiates [Presence] in Urine

105

591

1.82

7.48

2.3

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

277

2.20

7.45

1.6

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

102

571

1.83

7.39

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

435

1.95

7.36

1.1

u/ml

1.6

4.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

143

2.69

7.33

2.5

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

475

1.89

7.16

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

365

2.01

7.03

2.8

1.9

g/l

0.0

0.00

338

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

368

1.99

6.88

2.8

1.9

g/l

0.0

0.00

339

(3017354) Segmented neutrophils/100 leukocytes in Blood

125

2.75

6.87

3.1

3.9

58.6

56.9

0.16

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

131

806

1.67

6.84

2.0

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1756

16602

1.42

6.83

4.8

4.1

mmol/l

4.7

2.78

1644

15440

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.45

6.77

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.28

6.75

1.3

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

138

2.64

6.73

4.0

4.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

193

2.36

6.66

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

403

1.92

6.55

2.2

2.1

mg/l

11.7

11.4

0.12

377

(3027944) Amphetamines [Presence] in Urine

101

588

1.76

6.46

2.3

1.9

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

4.85

6.45

1.2

1.0

mg/g

12.3

7.6

0.39

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

392

1.92

6.40

2.8

1.9

g/l

0.0

0.21

362

(46235355) HIV 1 and 2 tests - Meaningful Use set

376

2907

1.36

6.39

1.9

1.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.07

6.35

2.3

1.3

nmol/l

97.5

130.5

0.45

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

159

1046

1.56

6.34

2.2

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

403

1.89

6.23

1.3

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

111

671

1.69

6.22

2.6

2.4

1.7

1.2

2.99

111

666

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

168

2.41

6.22

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

168

2.41

6.22

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

168

2.41

6.22

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.69

6.21

1.2

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

169

2.39

6.14

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.41

6.14

1.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.04

6.08

1.2

1.4

—

(3003181) Sodium [Moles/volume] in Urine

234

2.17

6.06

1.3

mmol/l

61.5

61.9

0.02

184

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

2.73

6.02

1.9

2.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

117

2.68

6.00

1.9

2.1

77.8

72.3

1.23

111

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

171

2.37

5.99

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

224

1602

1.45

5.98

2.1

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.00

5.96

1.2

1.4

—

(3023419) Bacteria identified in Sputum by Culture

179

2.32

5.87

2.2

2.6

—

(3044941) Cell count panel - Synovial fluid

179

2.32

5.87

1.3

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.41

5.86

1.2

g/l

0.3

1.08

(3045414) Leukocytes [Presence] in Urine

108

660

1.67

5.83

1.5

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.80

5.81

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.80

5.81

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

421

1.84

5.77

1.5

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

5.02

5.74

7.2

6.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

101

609

1.69

5.73

1.7

1.8

g/l

1.7

1.5

0.84

527

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

246

1804

1.41

5.73

2.2

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

249

1831

1.41

5.71

5.1

4.3

31.8

32.4

0.33

179

1212

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

240

2.11

5.71

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

315

2409

1.36

5.70

1.6

—

(3003338) MCHC [Mass/volume]

1554

14524

1.30

5.70

27.1

15.8

g/l

332.2

332.4

0.26

1547

14397

(21494755) Public health laboratory ask at order entry panel

121

1851

0.63

5.67

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

109

2.68

5.67

1.3

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

170

2.32

5.61

1.4

1.5

—

(40761535) Cells panel - Urine sediment

169

1166

1.49

5.43

3.7

3.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

148

2.39

5.40

1.1

1.2

u/l

61.1

56.8

0.19

105

(40767503) Oxygen content in Capillary blood by calculation

266

2.02

5.39

2.1

2.5

17.6

16.4

1.22

130

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

239

2.08

5.38

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.04

5.38

3.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

351

1.88

5.36

1.5

1.7

—

(3000991) Gas panel - Venous blood

173

1206

1.47

5.29

9.7

8.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

175

1223

1.47

5.28

4.7

3.7

mmol/l

1.2

1.46

165

1052

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

114

2.57

5.22

2.0

2.1

14.6

12.3

0.26

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

176

2.24

5.21

2.6

2.1

mg/l

23.4

21.7

0.09

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.66

5.20

1.3

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

326

1.90

5.20

1.6

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

123

800

1.57

5.19

1.3

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1732

16499

1.34

5.05

4.8

4.0

mmol/l

1.4

1.5

7.82

1618

15254

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

308

1.91

5.05

4.3

5.7

iu/ml

196.3

767.1

—

(44790049)

172

2.23

5.05

1.7

1.6

—

(44806118)

172

2.23

5.05

1.7

1.6

—

(44790048)

172

2.23

5.05

1.7

1.6

—

(44790047)

172

2.23

5.05

1.7

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.58

5.05

1.1

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

344

1.86

5.04

1.5

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

410

1.78

5.03

1.1

1.2

titre

70.0

102.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

104

657

1.61

4.97

2.6

2.3

0.7

0.04

638

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.68

4.92

1.3

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

256

1.98

4.85

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.59

4.77

1.1

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.18

4.76

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

212

1565

1.40

4.76

4.1

3.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

206

2.06

4.59

1.4

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

297

1.88

4.58

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

297

1.88

4.58

1.5

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.63

4.56

1.3

1.4

30.5

30.9

0.02

(3004809) Band form neutrophils/100 leukocytes in Blood

214

2.03

4.53

3.6

3.7

2.0

1.1

0.95

169

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.73

4.51

1.9

1.7

—

(3000330) Specific gravity of Urine by Test strip

111

733

1.54

4.43

2.9

3.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

1.91

4.37

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

165

1187

1.42

4.31

1.4

1.5

—

(3021788) Differential panel - Synovial fluid

198

2.04

4.29

1.7

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.89

4.25

7.2

6.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.63

4.20

1.8

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.63

4.20

1.8

3.3

—

(1761868) Lipid panel - Serum or Plasma

548

6357

0.81

4.18

3.0

2.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

207

2.00

4.18

1.8

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

214

1.98

4.17

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

413

1.69

4.11

1.1

1.2

—

1157.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

110

2.38

4.07

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

3.94

3.98

1.1

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.03

3.96

3.4

2.4

—

(3027315) Oxygen [Partial pressure] in Blood

283

1.82

3.95

2.8

4.2

kpa

9.0

8.7

0.56

276

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1666

15908

1.26

3.92

4.3

3.7

mmol/l

1.4

1.3

6.96

1553

14635

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.44

3.90

6.7

6.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

345

2814

1.27

3.89

3.1

mmol/l

2.4

0.67

304

2483

(3006653) Thiamine [Moles/volume] in Blood

2.58

3.88

1.9

1.2

nmol/l

130.6

135.8

0.24

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

165

2.08

3.87

1.4

1.9

—

(3014271) Vancomycin [Susceptibility]

2.98

3.85

3.6

2.5

—

(3008295) Osmolality of Serum or Plasma

146

2.14

3.81

1.3

1.2

mosm/kgh2o

272.8

278.5

0.61

110

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

236

1.88

3.80

1.6

1.4

u/l

37.3

29.9

0.58

196

(3017446) Testosterone [Moles/volume] in Serum or Plasma

143

1029

1.42

3.76

2.6

2.1

nmol/l

12.8

13.1

0.15

121

907

(3010421) pH of Blood

350

1.71

3.67

3.3

3.9

7.4

0.32

276

(3012501) Base excess in Blood by calculation

283

1.79

3.65

2.7

4.2

mmol/l

1.6

2.5

2.50

183

(3036670) Protein [Mass/volume] in Synovial fluid

3.68

3.64

1.5

1.2

g/l

46.6

35.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.26

3.62

1.2

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

284

1.78

3.61

2.7

4.2

kpa

4.9

5.0

0.05

277

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

299

1.76

3.61

1.1

u/ml

290.4

250.7

0.44

183

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

237

1860

1.31

3.60

7.8

6.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

301

1.75

3.53

2.3

2.6

umol/l

30.6

34.3

0.90

254

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.31

3.51

1.2

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

734

0.56

3.44

1.3

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

483

4143

1.22

3.43

5.1

4.5

ug/l

2.8

3.2

0.19

443

3691

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

313

1.71

3.37

1.5

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.02

3.37

1.3

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

5.02

3.37

1.3

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

7.02

3.36

2.0

2.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.72

3.35

1.9

3.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.72

3.35

1.2

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

182

1.94

3.34

1.3

pmol/l

317.7

322.0

0.02

145

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.37

3.32

1.3

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

415

1.61

3.32

2.3

3.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

108

758

1.45

3.28

11.8

10.2

mmol/l

24.4

0.04

723

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.59

3.26

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

4.75

3.24

1.2

1.1

—

(3017704) Immunofixation for Urine

2.45

3.21

2.0

1.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.17

3.21

1.2

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.87

3.19

1.5

3.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.35

3.19

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.97

3.13

2.3

2.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.52

3.05

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

119

2.11

3.04

1.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

262

1.73

3.04

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

240

1.77

3.03

5.4

5.8

umol/l

337.5

370.0

0.83

205

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.85

3.02

2.0

2.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.85

3.02

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.31

3.01

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.31

3.01

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.31

3.01

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

395

0.45

3.00

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

394

0.45

2.98

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

394

0.45

2.98

1.3

1.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

317

1.66

2.98

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

264

1.72

2.97

1.5

nmol/l

0.5

0.4

0.22

211

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

393

0.45

2.96

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

536

4704

1.19

2.93

1.3

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

3.15

2.93

2.0

2.1

e6/l

206.7

186.5

—

(3036489) Thrombin time

567

1.48

2.92

1.7

1.9

20.3

21.7

2.65

494

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.72

2.92

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.34

2.90

1.0

2.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

390

1.58

2.90

1.5

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

266

1.71

2.90

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.10

2.88

2.0

mmol/l

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

427

0.49

2.85

1.2

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

345

0.43

2.84

1.3

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.46

2.79

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

4.46

2.79

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

487

4255

1.19

2.79

1.8

1.6

mmol/l

1.6

1.4

1.66

405

3576

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

8.35

2.75

1.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

279

1.66

2.71

1.5

1.4

u/ml

112.1

126.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

2.60

2.70

1.0

1.1

—

4.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

234

1.72

2.69

1.4

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.98

2.69

1.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

335

0.44

2.65

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

333

0.45

2.62

1.3

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

120

2.01

2.61

1.1

1.4

mmol/l

13.3

11.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

141

1.93

2.60

4.3

5.1

u/ml

53.8

87.9

0.35

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

141

1.93

2.60

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

306

1.62

2.60

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

3.61

2.57

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.20

2.57

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.20

2.57

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.20

2.57

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

452

1.50

2.55

3.1

3.0

u/ml

0.4

0.3

0.31

247

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.14

2.55

1.7

2.9

40.8

40.2

0.04

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.74

2.54

1.5

1.3

—

(3024928) Oxygen saturation in Venous blood

309

1.60

2.51

3.2

2.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

180

1.79

2.48

3.0

2.3

—

(3036603) Volume of Urine

109

2.03

2.46

2.2

1.5

1546.5

1974.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

1.99

2.45

1.8

2.6

e6/l

824.4

628.3

0.65

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

384

3328

1.19

2.40

4.6

4.0

21.6

21.7

0.02

173

1530

(3030313) Adrenal Ab [Titer] in Serum

6.26

2.37

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.51

2.36

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

221

1.69

2.35

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

291

1.59

2.34

1.1

u/ml

0.8

1.9

0.61

113

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

133

1.89

2.31

1.2

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

133

1.89

2.31

1.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

133

1.89

2.31

1.2

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.19

2.31

2.1

2.0

u/field

1.6

4.1

0.58

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.49

2.27

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1018

0.71

2.26

1.5

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

113

1.96

2.25

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

201

1.70

2.25

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

442

1.46

2.21

2.2

2.4

g/l

3.6

0.05

420

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.34

2.18

1.3

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

173

1.75

2.17

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.69

2.15

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

437

1.46

2.14

1.6

1.9

iu/l

2.9

4.9

2.26

160

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.21

2.09

1.8

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.14

2.08

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.01

2.07

5.6

6.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

207

1.65

2.04

1.4

1.3

mmol/l

7.0

7.6

0.45

147

(3000492) Spirometry study

182

1490

1.24

2.04

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

154

1.76

2.04

1.4

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

175

0.40

2.03

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

147

1.78

2.02

5.0

4.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.11

2.02

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

141

1.78

1.97

3.1

2.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

165

1.71

1.91

1.5

1.6

—

25.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.93

1.90

5.7

6.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.19

1.88

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.19

1.88

1.3

ng/l

108.1

97.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.19

1.88

1.1

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

293

1.51

1.85

2.6

3.4

56.0

56.8

0.17

293

(3008401) Mugwort IgE Ab [Units/volume] in Serum

253

1.55

1.84

1.1

u/ml

3.1

1.2

0.36

103

(3024263) Appearance of Synovial fluid

2.21

1.84

1.1

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

222

1.59

1.82

1.2

—

(44813793)

108

1.86

1.81

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

207

1.60

1.80

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

2.77

1.79

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

474

0.63

1.79

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.17

1.77

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.17

1.77

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.03

1.75

1.2

1.1

miu/ml

1355.9

1593.4

0.31

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

1.74

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

143

1164

1.25

1.72

2.7

2.5

ml/min/173m2

68.0

67.8

0.02

448

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.67

1.72

1.4

1.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

2.14

1.71

2.2

1.1

umol/l

3.4

5.1

1.10

(3024891) Influenza virus A+B Ag [Presence] in Specimen

425

1.40

1.69

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

243

1.53

1.68

1.1

u/ml

0.4

3.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.16

1.66

1.0

1.2

umol/24h

1.5

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

487

1.37

1.65

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

127

1.74

1.64

2.6

3.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.25

1.63

1.9

2.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

191

1614

1.20

1.62

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

218

1866

1.19

1.61

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.33

1.60

2.8

3.1

mg/l

7.6

7.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.01

1.58

2.0

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

1.58

1.2

—

(3002256) Pathology report gross observation

245

2122

1.18

1.57

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

264

1.49

1.56

4.0

3.0

nmol/l

0.8

0.38

211

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.54

1.2

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.54

1.2

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.54

1.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.93

1.54

1.2

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

195

1660

1.19

1.54

3.1

4.3

ug/l

9.7

26.5

1.58

161

1334

(3045424) Erythrocytes [Presence] in Urine

257

1.49

1.53

1.3

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.52

0.0

2.0

—

2.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

477

1.35

1.52

1.7

2.0

95.7

91.0

0.79

437

(3003888) Timothy IgE Ab [Units/volume] in Serum

266

1.48

1.51

1.1

u/ml

3.0

6.6

1.17

129

(44806071)

2.86

1.50

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.86

1.50

2.3

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

124

1.70

1.47

2.0

2.3

—

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.85

1.46

1.3

1.2

—

(4146454)

142

1.63

1.38

3.0

2.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

582

1.30

1.38

2.6

3.8

u/ml

100.9

946.0

1.79

510

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

247

1.47

1.38

1.4

1.8

—

(3045142) Bone marrow Pathology biopsy report

182

1.55

1.37

1.3

1.4

—

(4133840)

2.20

1.37

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

383

1.37

1.36

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

418

1.35

2.1

1.6

—

(4306422)

224

1.48

1.34

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.78

1.33

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

113

1.69

1.32

1.1

1.2

u/ml

0.6

0.7

0.12

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.50

1.30

1.3

1.1

—

(21494434) Karyotype in Bone marrow

129

1.63

1.30

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

1.70

1.29

1.2

1.7

u/l

7.3

6.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.78

1.28

3.2

3.1

u/field

0.6

0.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

370

1.36

1.28

4.3

3.9

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

353

0.65

1.27

1.5

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

146

1718

0.84

1.27

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.74

1.25

1.1

iu/ml

5.4

13.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.40

1.24

1.7

2.0

umol/l

6.2

14.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.91

1.22

1.3

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.91

1.22

1.2

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.91

1.22

1.2

2.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

1.97

1.22

1.1

6.8

mg/l

50.3

60.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.64

1.21

1.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.84

1.19

1.8

3.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.31

1.18

1.7

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

102

1.67

1.16

1.0

ng/l

634.2

672.0

0.24

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.06

1.15

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

126

1.59

1.14

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

597

0.75

1.14

1.4

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

103

1.66

1.12

1.0

ng/l

226.1

328.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.34

1.12

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.34

1.12

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.34

1.12

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.34

1.12

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.26

1.10

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

104

1.64

1.09

1.0

ng/l

32.0

43.9

—

(3047189) Immunofixation for 24 hour Urine

1.82

1.09

1.8

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

505

1.28

1.09

1.4

1.3

miu/ml

167.1

219.1

0.77

248

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.19

1.08

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

1.62

1.06

2.1

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.80

1.04

1.6

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.96

1.03

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

138

1.53

1.03

1.5

1.4

g/l

0.9

1.0

0.49

138

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

298

1.35

1.02

1.2

—

(3004451) EKG impression Narrative

1.77

1.00

1.5

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.00

1.3

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.84

0.98

5.9

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.86

0.96

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.80

0.96

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.80

0.96

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

158

1.46

0.93

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

158

1.46

0.93

2.1

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

201

1.40

0.91

1.2

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

102

1.57

0.90

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

185

1.41

0.89

1.2

1.1

—

(40761536) Microorganisms panel - Urine sediment

152

1336

1.15

0.89

4.8

3.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

263

1.34

0.88

1.9

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.72

0.86

1.0

1.2

iu/ml

101.9

217.6

1.85

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

120

1.50

0.85

2.2

2.5

u/field

1.6

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.57

0.84

1.2

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.78

0.84

1.1

1.2

pmol/l

270.3

320.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

196

1.38

0.84

1.5

1.6

—

(3048879) Bone marrow aspiration report

1.77

0.76

1.5

2.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.77

0.76

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

175

1.38

0.74

1.2

—

(4034850)

496

1.22

0.74

11.8

8.4

—

(40758292) HTLV I+II Ab panel - Serum

2.00

0.72

1.2

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.00

0.72

1.4

1.3

ng/l

345.4

100.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

176

1.37

0.72

1.6

2.1

umol/l

4.6

5.7

0.45

125

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.53

0.72

1.2

1.3

—

(3000012) Reticulocyte production index

1.58

0.71

1.1

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

674

1.18

0.71

2.1

1.7

mg/l

3.1

4.9

0.75

456

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.93

0.70

1.8

3.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.85

0.68

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.85

0.68

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.85

0.68

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.53

0.68

33.7

31.2

ug/l

6.3

7.9

—

(40768793) Breast Pathology biopsy report

440

0.79

0.67

1.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

223

1.30

0.66

1.2

u/ml

2.8

3.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.53

0.66

2.4

1.6

—

(4024509)

128

1.41

0.65

1.9

1.6

—

(3025130) Human papilloma virus identified in Specimen

252

1.27

0.62

1.5

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.55

0.62

3.2

3.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.67

0.61

1.0

1.7

—

(40768441) Liver Pathology biopsy report

113

1.42

0.61

1.6

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

183

1.32

0.59

2.3

2.5

—

(3042631) Mycobacterium sp identified in Specimen

183

1.32

0.59

2.8

2.9

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.59

0.0

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.51

0.58

1.6

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

149

1.35

0.57

1.5

1.8

—

(4015189)

1.72

0.57

2.0

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

202

1.29

0.57

1.0

1.1

u/ml

2.2

3.8

0.38

(40768800) Prostate Pathology biopsy report

264

0.76

0.57

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.48

0.53

4.4

4.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.43

0.52

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

1.41

0.51

1.6

3.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.49

0.49

2.5

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

101

1.39

0.49

3.5

1.9

—

(3015183) Erythrocyte sedimentation rate

1.43

0.49

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

666

0.87

0.47

1.2

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.43

0.46

1.3

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.39

0.46

1.2

1.3

u/l

13.6

10.0

0.61

(3002523) Influenza virus A Ag [Presence] in Specimen

293

1.20

0.44

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

293

1.20

0.44

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

105

1153

0.91

0.43

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

405

1.16

0.43

2.0

2.9

mg/l

1.6

1.5

0.22

372

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

221

1.22

0.42

1.1

127.2

115.8

1.35

200

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.64

0.42

1.2

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.56

0.42

1.4

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.41

0.42

2.8

1.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.41

0.0

1.0

—

19.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

260

0.81

0.40

1.2

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

223

1.21

0.39

1.0

1.1

u/ml

1.1

3.1

1.09

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.43

0.39

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.00

0.39

0.0

1.1

—

1.6

—

(4094501)

429

1.15

0.38

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

336

1.16

0.37

4.4

3.5

mg/l

20.8

24.8

0.44

210

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.33

0.37

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

107

1.31

0.37

2.3

2.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

125

1.28

0.37

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.27

0.36

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.27

0.36

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.35

1.3

1.1

—

(40768806) Pleura Pathology biopsy report

144

1.25

0.35

1.4

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

117

1.28

0.35

2.2

1.6

—

(44806420)

1.31

0.33

1.7

2.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

232

2433

0.95

0.32

3.0

2.8

ug/l

0.8

0.7

0.20

152

1539

(3019832) Treponema pallidum Ab [Presence] in Serum

160

1508

1.07

0.31

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.71

0.30

1.3

1.4

—

(4035726)

159

1501

1.06

0.30

1.3

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.27

0.30

1.3

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

102

1.28

0.30

1.5

1.6

mmol/l

8.6

7.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

313

0.86

0.29

1.2

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

177

1.19

0.27

1.0

1.1

u/ml

0.1

0.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

234

1.16

0.26

1.2

u/ml

1.8

5.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

339

1.12

0.25

1.8

1.9

nmol/l

0.8

0.29

289

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

264

1.14

0.24

4.0

3.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.25

0.24

1.0

—

(1002224) Polysomnography panel

716

1.08

0.24

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

237

1.14

0.23

1.1

u/ml

1.7

2.3

0.41

114

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

312

3024

1.04

0.23

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.24

0.23

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.25

0.22

1.4

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

107

1.22

0.21

1.2

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.8

—

10.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

2.0

—

2.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

4.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.13

0.18

1.5

1.3

—

(3028433) Virus identified in Specimen by Culture

1.21

0.18

1.0

1.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.19

0.18

1.0

1.1

—

9.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

163

0.86

0.17

1.0

—

(3045788) Cell count panel - Pleural fluid

131

0.84

0.17

1.1

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

167

1.14

0.17

2.7

3.8

u/ml

86.6

41.2

0.57

167

(3035880) pH of Pleural fluid

1.16

0.16

1.1

1.3

—

(4211845)

1.14

0.16

5.3

2.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.15

0.15

1.2

2.0

—

(3012441) Differential panel - Pleural fluid

141

1.14

0.14

1.4

—

(3011648) Oxygen content in Venous blood

106

0.85

0.13

1.4

1.8

10.2

11.3

—

106

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

1.15

0.12

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

435

0.94

0.11

1.5

pmol/l

72.9

163.4

2.16

428

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

319

1.07

0.10

2.1

2.4

ug/min

46.1

88.7

0.97

197

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.14

0.10

2.0

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.05

0.08

2.0

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

107

1.12

0.08

1.4

—

75.6

—

(3006462) Nitrate [Presence] in Urine

1.08

0.08

5.9

2.7

—

(3012565) Volume of 24 hour Urine

1.03

0.07

2.5

2.7

2216.3

1998.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.07

0.07

1.6

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

305

1.05

0.06

1.3

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

129

1.09

0.05

1.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

110

0.91

0.05

1.1

—

(4268621)

150

1.07

0.04

2.1

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

161

1.06

0.03

1.1

104.2

95.3

0.60

152

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

171

1.05

0.03

1.2

—

(40768795) Lymph node Pathology biopsy report

189

0.95

0.03

1.2

—

(4281824)

211

1.04

0.03

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

112

1.07

0.03

1.2

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

163

1.04

0.01

1.2

1.4

e6/l

2022.5

1597.6

0.27

113

(3051611) Lipemic interference index of Serum or Plasma

155

0.97

0.00

1.5

3.4

—

(3051651) Icteric interference index of Serum or Plasma

1.01

0.00

1.0

3.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

185

1.03

0.00

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

231

1.00

0.00

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

267

1.01

0.00

1.5

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

2.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

179.8

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

0.9

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.8

—

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.3

—

47.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.91

0.00

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

3.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

3.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_NEURALGIA and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_NEURALGIA	1.285 [1.13, 1.47]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.137

During the follow-up period (1.1.1998 — 31.12.2019), 788 out of 6263 females with M13_NEURALGIA died.

Males

Parameter	HR [95% CI]	p-value
M13_NEURALGIA	1.324 [1.16, 1.52]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 732 out of 4315 males with M13_NEURALGIA died.

Mortality risk

Mortality risk for people of age

years, who have M13_NEURALGIA.

N-year risk	Females	Males
1	0.08%	0.252%
5	0.62%	1.395%
10	1.644%	3.671%
15	3.231%	7.091%
20	6.008%	12.535%

Relationships between endpoints

↥

Index endpoint: M13_NEURALGIA – Neuralgia and neuritis, unspecified

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Neuralgia and neuritis, unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints